Arthrogryposis clinical trials
The registry lists 85 studies for Arthrogryposis across more than 10 countries. 10 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-08-18.
Status
- Completed
- 49
- Status unknown
- 11
- Terminated
- 8
- Recruiting
- 5
- Active, not recruiting
- 4
- Withdrawn
- 3
Phase
- Phase 2
- 21
- Phase 3
- 17
- Phase 1
- 4
- Phase 4
- 3
Where
- United States
- 40
- France
- 14
- Italy
- 11
- Australia
- 10
- United Kingdom
- 9
- Japan
- 9
Who runs them
Otsuka Pharmaceutical Development & Commercialization, Inc. (8) · University Hospital, Grenoble (5) · Otsuka Pharmaceutical Co., Ltd. (3) · Freeman-Sheldon Research Group, Inc. (3) · Mayo Clinic (3) · University of Colorado, Denver (3) · The Rogosin Institute (3) · Palladio Biosciences (2)
Studies
Recruiting first, then most recently updated. Showing 50 of 85 — search for more.
- Ready, Set, Go! A Physical Fitness Intervention for Children With Mobility ChallengesEnrolling by invitationNCT04789746Not applicable1 country
- Continuous Passive Motion Device for Children With ArthrogryposisNot yet recruitingNCT06192134Not applicable
- Impact Study on Users of Upper Limb Assistive DevicesRecruitingNCT074291881 country
- Piezo2-related Arthrogryposis & physiopathOLOgy 3Not yet recruitingNCT073605741 country
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruitingNCT017931682 countries
- Analysis of Patients With Autosomal Dominant Polycystic KidneyRecruitingNCT067591421 country
- Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease TreatmentRecruitingNCT06618638Not applicable1 country
- Technical Feasibility Study of Ultrasound Muscle Imaging in Antenatal UltrasoundNot yet recruitingNCT06130592Not applicable
- National Registry of Rare Kidney DiseasesRecruitingNCT060658521 country
- Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney DiseaseEnrolling by invitationNCT05870007Phase 21 country
- Effect of Beetroot Juice on Reducing Hypertension in Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT05401409Not applicable1 country
- A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCONTerminatedNCT03918447Phase 310 countries
- A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT05521191Phase 11 country
- NuroSleeve Powered Brace & Stimulation System to Restore Arm FunctionActive, not recruitingNCT04798378Not applicable1 country
- Study of Tamibarotene in Patients With ADPKDActive, not recruitingNCT06289998Phase 21 country
- Natural History of Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 MutationTerminatedNCT061403296 countries
- Genetic Testing and Motivational Counseling for FHActive, not recruitingNCT04656028Not applicable1 country
- Safety, Tolerability, and Efficacy of Encaleret in Participants With Autosomal Dominant Hypocalcemia (ADH) Type 1CompletedNCT04581629Phase 21 country
- A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)TerminatedNCT04578548Phase 27 countries
- WREX Outcome StudyCompletedNCT02218593
- A Clinical Trial of Water Therapy for Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT03102632Not applicable1 country
- Time Restricted Feeding in Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT04534985Not applicable1 country
- Assessment of Treatment With Laparoscopic Fenestration or Aspiration Sclerotherapy for Large Symptomatic Hepatic CystsStatus unknownNCT05500157Not applicable1 country
- Study of the Efficacy and Safety of Tesevatinib in Subjects With ADPKDCompletedNCT03203642Phase 21 country
- Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney DiseaseTerminatedNCT04064346Phase 38 countries
- Pediatric and Adult Registry for Patients With ARThrogryposisStatus unknownNCT056732651 country
- Arthrogryposis Multiplex Congenita in Pediatric Age: Correlation Between MUScular MRI and Functional EvaluationCompletedNCT053933751 country
- Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease)CompletedNCT02964273Phase 34 countries
- The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT03487913Phase 21 country
- A Safety, Pharmacokinetic & Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT01559363Phase 1/21 country
- Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT02656017Phase 21 country
- Survey Study and Records Review of Treatment Outcomes in Freeman-Sheldon SyndromeStatus unknownNCT054192451 country
- Survey Study and Records Review of Treatment Outcomes in Freeman-Sheldon SyndromeTerminatedNCT011447411 country
- Evaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Autosomal domInAnt poLycystic Kidney DiseaseCompletedNCT03949894Phase 41 country
- Study of Resting and Exercising Body Functioning in Freeman-Sheldon Syndrome and Related ConditionsWithdrawnNCT013069941 country
- A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO GeneActive, not recruitingNCT04123626Phase 1/21 country
- Daily Caloric Restriction and Intermittent Fasting in Overweight and Obese Adults With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT03342742Not applicable1 country
- A Study of RGLS4326 in Patients With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT04536688Phase 11 country
- Mercuri Analysis Contribution on Handicap Evaluation in ArthrogypOsis, a Congenital Neuromuscular DiseaseCompletedNCT051377561 country
- Tolvaptan Extension Study in Participants With ADPKDCompletedNCT01214421Phase 313 countries
- A Study to Determine the Effects of NPSP795 on the Calcium-sensing Receptor in Subjects With Autosomal Dominant Hypocalcemia as Measured by PTH Levels and Blood Calcium ConcentrationsCompletedNCT02204579Phase 21 country
- Clinical and Molecular Description of PKD1 and PKD2 Mutation Negative Carriers in ADPKDCompletedNCT02112136Not applicable1 country
- Using Preimplantation Genetic Diagnosis in Autosomal Dominant Polycystic Kidney Disease Patients: a Multicenter Clinical TrialCompletedNCT02948179Not applicable1 country
- Wishing to Decrease Aquaresis in ADPKD Patients Treated With a V2Ra; the Effect of Regulating Protein and SaltStatus unknownNCT04310319Not applicable1 country
- Pasireotide LAR in Severe Polycystic Liver DiseaseCompletedNCT01670110Phase 21 country
- The Kidneys Ability to Concentrate and Dilute Urine in Patients With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT04363554Not applicable1 country
- Long Term Safety of Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT02251275Phase 320 countries
- Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project.CompletedNCT02233322Not applicable1 country
- The Safety and Efficacy of Catheter-based Renal Denervation Using the Vessix™ Renal Denervation System in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients With Severe Debilitating PainWithdrawnNCT02746419Not applicable
- Short-term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)CompletedNCT01336972Phase 21 country